oral contraceptives Tagged Articles

FDA panel warns of elevated blood clot risk with patch, Yaz

Posted: December 28, 2011 Pharmaceutical

A Food and Drug Administration (FDA) advisory panel said Friday that the Ortho Evra birth control patch, made by Johnson & Johnson, should remain on the market despite an elevated risk for blood clots. The panel voted 19-5 in favor

Blood clot warnings on birth control pills could impact user rates

Posted: December 27, 2011 Pharmaceutical

Stronger warnings on packages of a newer class of birth control pills and government ruling to restrict the availability of the morning-after pill may make women leery of birth control in general, which could increase the rate of unwanted pregnancies

Why would FDA panel not ban Yaz over blood clot risk?

Posted: December 23, 2011 Pharmaceutical

Why did an advisory panel of experts for the Food and Drug Administration (FDA) not vote to ban the popular birth control pill Yaz and other pills of its generation containing the hormone drospirenone, instead opting to recommend that the

New studies show increased risk of blood clots with Yaz

Posted: December 22, 2011 Pharmaceutical

A new study backs up concerns of previous studies that show birth control pills containing the hormone drospirenone, such as Yaz and Yasmin, are more likely to cause deadly blood clots than oral contraceptives made with older generation hormones.

FDA approves generic Yaz despite serious blood clot warnings

Posted: December 21, 2011 Pharmaceutical

Yaz, and other birth control pills made with the hormone drospirenone, have been shown in studies to put women at greater risk for developing deadly blood clots, yet generic versions of the drug are still being approved for sale in

FDA panel member stripped of voting rights in Yaz-blood clot safety review

Posted: December 14, 2011 Pharmaceutical

Sid Wolfe, head of the Public Citizen Health Research Group, was stripped of his voting rights on a Food and Drug Administration (FDA) advisory panel just before the committee was to review the safety of the popular birth control pills

FDA panel recommends stricter blood clot warnings on Yaz

Posted: December 12, 2011 Pharmaceutical

Packs of Yaz and other birth control pills containing the hormone drospirenone should be updated to include a warning that the pills may be more likely to cause life threatening blood clots than older oral contraceptives, according to a Food

Could birth control pills cause prostate cancer in men?

Posted: November 19, 2011 Pharmaceutical

It was a burning question in the minds of Dr. Neil Fleshner, a urologic oncologist and researcher at Princess Margaret Hospital in Toronto and a colleague – why do men in North America and Europe develop and die of prostate

Another study suggests Yaz carries greater risk for blood clots

Posted: November 15, 2011 Product Liability

Another study confirms that birth control pills containing the hormone drospirenone are more likely to cause life threatening blood clots than oral contraceptives with older generation hormones. The study, released Monday, involves 330,000 Israeli women. Researchers concluded that the blood

FDA: Yaz, Yasmin put users at risk for dangerous blood clots

Posted: November 2, 2011 Product Liability

Drug regulators will take a closer look at the birth control pills containing the hormone drospirenone, such as Bayer’s popular pills Yaz and Yasmin, during a meeting with advisers next month. At issue is the safety of the pills, which the